Brief Description
With a portfolio of existing IP, DNA Nanobots develops products for targeted therapeutics and functionalized gene delivery. We have a dual approach, building partnerships to provide development expertise in the functionalization of DNA nanotechnology with experience in Gene Delivery, Vaccine Development, Targeted Drug Delivery, Biosensing, Immunotherapy, and Drug Discovery.
Inventors
Jennifer Doudna, Enrique Lin Shiao, Rachael Lew
Company Founders
Patrick Halley, Christopher Lucas, Carlos Castro, Adel Mikhail, Melika Shahhosseini, Jeffrey Spitzner
Timeline
- 2021. Company founded.